Company / Total Assets
Upstream Bio, Inc. Total Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$353.8M
FY2025
5-year range
$117.2M / $481.7M
FY2023-FY2025
Trend
-26.6%
vs FY2024
Sector context
#169 of 214
Health Care
What the data says
Upstream Bio, Inc.'s total assets of $354M is lower than 79% of companies in the Health Care sector (FY2025). Improved from $117M to $354M over the past 2 years.
Based on SEC 10-K filings.
$354M in FY2025.
Improved from $117M to $354M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 214This company $353.8M Sector average $7.5B
▼
-95.3% below sector average
Key checks
Key Insights
- In FY2025, total assets decreased 26.6% year-over-year.
- Ranks #169 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $353.8M | -26.6% |
| FY2024 | $481.7M | +311.0% |
| FY2023 | $117.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026